Tybourne Capital Management (HK) Limited – Trademark Portfolio

Entity Type: 99

Tybourne Capital Management (HK) Limited holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 3 filings in this category. Currently, 3 trademarks are registered. Notable registered marks include TCM, TYBOURNE, and TCM TYBOURNE CAPITAL MANAGEMENT. The owner is based in Central.

30/F, AIA Central

1 Connaught Road

Central , HK

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Tybourne Capital Management (HK) Limited's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

36
Insurance & Financial (3 filings)

Insurance; financial affairs; monetary affairs; real estate affairs

Frequently Asked Questions

How many trademarks does Tybourne Capital Management (HK) Limited have?

Tybourne Capital Management (HK) Limited has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does Tybourne Capital Management (HK) Limited file in?

Tybourne Capital Management (HK) Limited files trademarks across 1 Nice Classification class. The most active classes are Class 36 (Insurance & Financial). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.

What are Tybourne Capital Management (HK) Limited's most well-known trademarks?

Tybourne Capital Management (HK) Limited's registered trademark portfolio includes well-known marks such as TCM, TYBOURNE, and TCM TYBOURNE CAPITAL MANAGEMENT. These are among 3 currently registered trademarks in the portfolio.

What is Tybourne Capital Management (HK) Limited's trademark registration success rate?

Tybourne Capital Management (HK) Limited has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.